By-health Co., Ltd. (300146.SZ) Bundle
Who is really behind By‑health Co., Ltd. (300146.SZ)? With insiders controlling around 45.8% of shares and the general public holding roughly 43.1%, ownership skews heavily toward insiders and retail investors rather than big institutions - institutional investors account for only about 9.9%, while private companies sit at 1.2%; the dominance of Yunchao Liang as the largest shareholder with 42.4% further concentrates influence, even as the top eight holders collectively command over 50% of the company. Major institutional names such as E Fund Management (1.63%), Shanghai Zhongping Capital (1.4%) and Qilu Zhongtai (1.14%) appear as modest stakeholders alongside insiders like Hong Chen (1.06%) and Shuisheng Liang (1.03%), and the market picture-market cap of CN¥20.49 billion, a low beta of 0.54, a dividend yield of 2.94%, a 2.26% intraday uptick on December 19, 2025, and a 4.53% year decline-frames investor sentiment and risk appetite; curious how these numbers shape governance, strategy and future performance? Keep reading to unpack who's buying By‑health and why.
By-health Co., Ltd. (300146.SZ) - Who Invests in By-health Co., Ltd. (300146.SZ) and Why?
Ownership of By-health Co., Ltd. is concentrated among individual insiders and retail holders, with limited institutional and corporate participation. These ownership patterns reflect investor confidence, sector characteristics, and market positioning.
- Individual insiders: ~45.8% - founders, management and employees signaling strong alignment with long-term strategy and confidence in growth prospects.
- General public (retail investors): ~43.1% - broad retail interest driven by brand recognition, consumer health trends, and dividend/earnings expectations.
- Institutional investors: ~9.9% - cautious engagement from funds and asset managers, often selective due to market cap, liquidity or valuation considerations.
- Private companies: ~1.2% - limited strategic corporate stakes, indicating few corporate partnerships or M&A-driven ownership.
| Investor Category | Approx. Ownership | Primary Motivations | Typical Horizon / Behavior |
|---|---|---|---|
| Individual insiders | 45.8% | Long-term capital appreciation, control, executing strategy | Long-term; low turnover |
| General public (retail) | 43.1% | Brand loyalty, growth/earnings expectations, trading on retail sentiment | Short-medium term; higher turnover |
| Institutional investors | 9.9% | Fundamental/quantitative allocation, risk-managed exposure to healthcare consumer sector | Medium-long term; selective positions |
| Private companies | 1.2% | Strategic minority stakes, partnership potential | Strategic; opportunistic |
Top-shareholder concentration: the top eight shareholders (a mix of insiders and institutions) collectively hold >50% of shares, balancing control with public float and reducing takeover vulnerability while maintaining governance alignment.
- Why insiders dominate: high insider stake provides management credibility to investors and signals commitment to the company's medium- to long-term roadmap.
- Why retail participation is large: consumer-facing product portfolio and frequent retail coverage in China's A-share market attract individual investors.
- Why institutions are limited: institutional allocation is restrained by portfolio mandates, relative valuation, and preference for larger, more liquid healthcare or consumer staples names.
- Hedge fund involvement: notable absence of significant hedge fund positions - indicative that hedge funds prefer larger-cap or event-driven targets over stable consumer-health plays like By-health.
For additional context on corporate direction and guiding principles that influence investor interest, see: Mission Statement, Vision, & Core Values (2026) of By-health Co., Ltd.
By-health Co., Ltd. (300146.SZ) Institutional Ownership and Major Shareholders of By-health Co., Ltd.
By-health Co., Ltd.'s shareholder mix shown below highlights a blend of institutional investors and insiders holding meaningful minority stakes. The named investors and insiders collectively account for 7.12% of outstanding shares, reflecting concentrated but non-controlling positions that can influence governance and market perception.- E Fund Management Co., Ltd. - 1.63% (institutional investor, conservative allocation)
- Shanghai Zhongping Capital Co., Ltd. - 1.40% (institutional investor, moderate strategic stake)
- Qilu Zhongtai Private Equity Fund Co., Ltd. - 1.14% (private equity-style holding)
- Hong Chen - 1.06% (individual insider)
- Shuisheng Liang - 1.03% (individual insider)
- China Southern Asset Management Co., Ltd. - 0.86% (institutional investor)
| Shareholder | Type | Reported Ownership (%) | Notes |
|---|---|---|---|
| E Fund Management Co., Ltd. | Institutional | 1.63 | Large national asset manager; typically represents diversified fund allocations |
| Shanghai Zhongping Capital Co., Ltd. | Institutional | 1.40 | Regional investment firm with strategic stakes in consumer-health companies |
| Qilu Zhongtai Private Equity Fund Co., Ltd. | Private Equity | 1.14 | Private-equity style investor focused on mid-cap growth opportunities |
| Hong Chen | Insider | 1.06 | Key individual insider; aligns personal wealth with company performance |
| Shuisheng Liang | Insider | 1.03 | Member of insider ownership base |
| China Southern Asset Management Co., Ltd. | Institutional | 0.86 | Significant national asset manager indicating institutional interest |
| Total (listed holders) | 7.12 | Sum of the above named holdings |
By-health Co., Ltd. (300146.SZ) - Key Investors and Their Impact on By-health Co., Ltd.
By-health Co., Ltd. (300146.SZ) exhibits a shareholder profile dominated by a controlling founder-type investor and supported by a mix of institutional, private equity and insider holdings. The following outlines the principal holders, their ownership percentages and the likely strategic and governance impacts of each.- Yunchao Liang - 42.4%: dominant controlling shareholder with decisive influence on board composition, capital allocation, M&A appetite and long-term strategy.
- E Fund Management Co., Ltd. - 1.63%: modest institutional stake that signals cautious interest from asset managers without independent voting power to alter outcomes.
- Shanghai Zhongping Capital Co., Ltd. - 1.4%: medium-sized strategic/financial investor with potential to participate in blockholder discussions or co-investments.
- Qilu Zhongtai Private Equity Fund Co., Ltd. - 1.14%: private equity-style stake that could involve active engagement on performance improvement or value-extraction initiatives.
- Hong Chen - 1.06%: insider ownership aligning management incentives with shareholder returns and governance stability.
- Shuisheng Liang - 1.03%: additional insider holding that reinforces family/management control and continuity.
| Investor | Ownership (%) | Investor Type | Likely Influence |
|---|---|---|---|
| Yunchao Liang | 42.4 | Founder/Controlling Shareholder | Control of strategic direction, board appointments, veto over major corporate actions |
| E Fund Management Co., Ltd. | 1.63 | Asset Manager / Institutional | Voice in governance via engagement; limited vote share |
| Shanghai Zhongping Capital Co., Ltd. | 1.4 | Strategic/Investment Firm | Moderate influence; potential co-investment partner |
| Qilu Zhongtai Private Equity Fund Co., Ltd. | 1.14 | Private Equity | Possible active involvement in operational or financial restructuring proposals |
| Hong Chen | 1.06 | Insider / Executive | Alignment of management incentives with shareholder value |
| Shuisheng Liang | 1.03 | Insider / Related Party | Supports family/insider control, continuity in governance |
- Governance dynamics: With a 42.4% controlling stake, Yunchao Liang effectively steers major decisions; minority holders cumulatively hold meaningful economic exposure but limited blocking power on routine corporate actions.
- Institutional signal: E Fund's ~1.63% indicates selective institutional allocation to the sector/company, useful for liquidity and secondary-market support but not a governance driver.
- Private equity posture: Qilu Zhongtai's 1.14% implies readiness to pursue value-enhancement measures; such investors often push for efficiency, product portfolio optimization or exit timelines.
- Insider alignment: Combined insider stakes (Hong Chen, Shuisheng Liang, others) above ~2% strengthen management-shareholder alignment and reduce risk of abrupt strategic shifts absent founder consent.
- Implications for minority investors: Concentrated ownership increases policy predictability but raises takeover/exit complexity and minority-protection considerations.
By-health Co., Ltd. (300146.SZ) Market Impact and Investor Sentiment
By-health Co., Ltd. (300146.SZ) presents a mixed but structurally appealing profile for a range of investors. Market capitalization of approximately CN¥20.49 billion (as of December 19, 2025) and a dividend yield of 2.94% combine valuation scale with income characteristics, while a beta of 0.54 signals lower systematic risk relative to the broader market. Recent price action-a 2.26% increase on December 19, 2025-points to short-term positive sentiment, offset by a 4.53% decline over the past year that reflects broader headwinds or company-specific concerns. The relative lack of significant hedge fund ownership further characterizes the shareholder base toward retail, institutional long-only, and income-oriented investors.- Market cap: CN¥20.49 billion (12/19/2025)
- Beta: 0.54 - lower volatility profile
- Daily move: +2.26% (12/19/2025)
- 1-year change: -4.53%
- Dividend yield: 2.94% - income stability
- Hedge fund exposure: minimal / no significant holdings reported
| Metric | Value | Implication |
|---|---|---|
| Market Capitalization | CN¥20.49 billion (12/19/2025) | Mid-cap scale; accessible to institutional and retail |
| Beta (5Y) | 0.54 | Defensive characteristics vs. market |
| Price Change (1 Day) | +2.26% (12/19/2025) | Positive short-term investor reaction |
| Price Change (1 Year) | -4.53% | Moderate annual drawdown; signals caution |
| Dividend Yield | 2.94% | Attractive for income-seeking investors |
| Hedge Fund Ownership | Insignificant / none | Less activist or event-driven interest |
- Primary buyer types:
- Retail investors drawn by brand recognition and yield
- Institutional long-only funds favoring stable-beta, dividend-paying equities
- Risk-averse portfolios seeking diversification with lower volatility exposure
- Potential seller pressure:
- Investors responding to near-term revenue or margin concerns (explaining the 1-year decline)
- Traders capitalizing on short-term volatility despite low beta
By-health Co., Ltd. (300146.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.